James Matcham - Concepedia

Author

James Matcham

Amgen (United Kingdom)

Also Known As

Gary Price, J Matcham, J. MATCHAM, J. Matcham, James Matcham, Katy Cooper, Matcham, James

Publications

Citations

H-Index

Concepts

All Affiliations

Amgen (United Kingdom)The Royal Melbourne Hospital University of Toronto Goethe University Frankfurt Roche (Switzerland)

About

James Matcham is an author at Amgen (United Kingdom) specializing in medicine, health sciences, and pharmacotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	4	4	83
2	Business	1	1	21
3	Education	1	1	18
4	Engineering	1	1	94
5	Management	1	1	21

James Matcham

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Randomized controlled trial of intraputamenal glial cell line–derived neurotrophic factor infusion in Parkinson disease Anthony E. Lang, Steven S. Gill, Nikunj K. Patel, Annals of Neurology	2006	972
A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of Filgrastim in Remission Induction and Consolidation Therapy for Adults With De Novo Acute Myeloid Leukemia Gerhard Heil, Dieter Hoelzer, Miguel Á. Sanz, Blood	1997	331
Efficacy and safety of darbepoetin alfa in anaemic patients with lymphoproliferative malignancies: a randomized, double‐blind, placebo‐controlled study Michael Hedenus, Magnus Adriansson, Jesús F. San Miguel, British Journal of Haematology	2003	325
A Randomized, Double-Blind, Placebo-Controlled Study With Pegylated Recombinant Human Megakaryocyte Growth and Development Factor (PEG-rHuMGDF) as an Adjunct to Chemotherapy for Adults With De Novo Acute Myeloid Leukemia E Archimbaud, Oliver G. Ottmann, John A. Liu Yin, Blood	1999	119
The effect of climatic factors on Colletotrichum gloeosporioides, causal agent of mango anthracnose, in the Philippines J. Dodd, A.B. Estrada, James Matcham, Plant Pathology EngineeringBotanyAgricultural EconomicsPlant PathologyTree Disease	1991	94
Differences between graft product and donor side effects following bone marrow or stem cell donation Gilles Favre, Meral Beksaç, Andrea Bacigalupo, Bone Marrow Transplantation Stem Cell DonationTransplantationMarrow TransplantationStem Cell TransplantationHematology	2003	88
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial. Norbert Schmitz, Meral Beksaç, Andrea Bacigalupo, PubMed	2005	68
Decision‐making in early clinical drug development Paul Frewer, Pat Mitchell, Claire Watkins, Pharmaceutical Statistics	2016	49
Imprecision of counting CFU-GM colonies and CD34-expressing cells Stefan Serke, Lubomir Arseniev, Mike Watts, Bone Marrow Transplantation Human CellCell DivisionMedicineComputational BiologyCfu-gm Colonies	1997	45
Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance Christina Yap, Olga Solovyeva, Johann S. de Bono, BMJ	2023	43

Page 1